Prescription drug · ANDA
Triazolam NDC 50090-6471
Triazolam .25 mg/1 · Tablet · Oral · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-6471-0 | 50090647100 | 30 TABLET in 1 BOTTLE (50090-6471-0)Marketed from May 9, 2023 | |
| 50090-6471-1 | 50090647101 | 100 TABLET in 1 BOTTLE (50090-6471-1)Marketed from May 9, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Triazolam
- Generic name (nonproprietary)
- triazolam
- Active ingredients
- Triazolam — .25 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- A-S Medication SolutionsNDC labeler code 50090
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214219
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Benzodiazepines (Chemical structure)
- Identifiers
- Product ID 50090-6471_c9dae524-0feb-4ff7-beba-8d28fde03caeSPL ID c9dae524-0feb-4ff7-beba-8d28fde03caeSPL set ID 5a330f08-5d8f-4f8d-8847-a45b734412b4RxCUI 198318UNII 1HM943223R
- Pharmacologic class
- Benzodiazepine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450090647100followed by a unit qualifier and the quantityPackage 50090-6471-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Triazolam is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. Triazolam is a benzodiazepine indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 50090-6471
- What is NDC 50090-6471?
- 50090-6471 is the product NDC for Triazolam, Triazolam .25 mg/1 tablet, listed with the FDA by A-S Medication Solutions. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Triazolam.
- What is the active ingredient?
- Triazolam.
- Who is the labeler?
- A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Triazolam?
- 13 other product NDCs are listed under this name. See all Triazolam NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Triazolam products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Triazolam | Triazolam .25 mg/1 | TabletOral | A-S Medication Solutions | 50090-7787 | 50090-7787-0050090-7787-01 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1289 | 70710-1289-0170710-1289-0570710-1289-08 |
| Triazolam | Triazolam .125 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1521 | 70710-1521-0170710-1521-0570710-1521-08 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1162 | 70771-1162-0170771-1162-0570771-1162-08 |
| Triazolam | Triazolam .125 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1576 | 70771-1576-0170771-1576-0570771-1576-08 |
| Triazolam | Triazolam .125 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-645 | 50742-0645-01 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-646 | 50742-0646-0150742-0646-05 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1876 | 71335-1876-0071335-1876-0171335-1876-02+7 more |
| Triazolam | Triazolam .25 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-349 | 72789-0349-30 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Proficient Rx LP | 82804-275 | 82804-0275-30 |
Other NDCs under ANDA 214219
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Triazolam | Triazolam .125 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-645 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Ingenus Pharmaceuticals, LLC | 50742-646 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1876 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 72789-349 |
| Triazolam | Triazolam .25 mg/1 | TabletOral | Proficient Rx LP | 82804-275 |